Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study

In conclusion, in addition to the known anti-cancer benefits of adjuvant zoledronate, there are likely to be positive, lasting benefits in BMD and bone turnover.PMID:38630878 | DOI:10.1093/jbmr/zjad006

Source: Cancer Control - April 17, 2024 Category: Cancer & Oncology Authors: Janet Brown Margaret A Paggiosi Emma Rathbone Walter Gregory Gian Bertelli Omar Din Eugene McCloskey David Dodwell David Cameron Richard Eastell Robert Coleman Source Type: research